Catastrophic antiphospholipid syndrome as a complication of systemic sclerosis
Submitted: 7 February 2018
Accepted: 17 December 2018
Published: 9 July 2019
Accepted: 17 December 2018
Abstract Views: 1227
PDF: 931
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Similar Articles
- W. Grassi, C. Montecucco, Approved indications and other possible utilizations of anti-TNFa biologic drugs , Reumatismo: Vol. 57 No. s4 (2005)
- M. Cazzola, P. Sarzi-Puttini, S. Stisi, M. Di Franco, L. Bazzichi, R. Carignola, R.H Gracely, F. Salaffi, F. Marinangeli, R. Torta, M.A. Giamberardino, D. Buskila, M. Spath, G. Biasi, G. Cassisi, R. Casale, L. Altomonte, G. Arioli, A. Alciati, A. Marsico, F. Ceccherelli, G. Leardini, R. Gorla, F. Atzeni, Fibromyalgia syndrome: definition and diagnostic aspects , Reumatismo: Vol. 60 No. s1 (2008)
- D.H.S. Attia, R.A. Abdel Noor, Severe Behçet’s disease equally affects both genders in Egyptian patients: A multicentre retrospective follow-up study , Reumatismo: Vol. 71 No. 4 (2019)
- M.A. Cimmino, A. Zampogna, S. Murroni, S. Baruffi, G. Alessio, T. Maio, G.S. Mela, Prevalence studies in rheumatology: the methodology of the Chiavari study , Reumatismo: Vol. 54 No. 1 (2002)
- L.J. Dominguez, M. Muratore, E. Quarta, G. Zagone, M. Barbagallo, Osteoporosis and diabetes , Reumatismo: Vol. 56 No. 4 (2004)
- M. Parodi, L. Bensi, T. Maio, G.S. Mela, M.A. Cimmino, Comorbidities in rheumatoid arthritis: analysis of hospital discharge records , Reumatismo: Vol. 57 No. 3 (2005)
- C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi, Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis , Reumatismo: Vol. 59 No. 1 (2007)
- M. Cazzola, P. Sarzi-Puttini, D. Buskila, F. Atzeni, Pharmacological treatment of fibromyalgia , Reumatismo: Vol. 59 No. 4 (2007)
- R. Ramírez-Sandoval, M. Vázquez-del-Mercado, A. Daneri-Navarro, E. López-Robles, J.J. Bollain-y-Goitia, E. Avalos-Diaz, R. Herrera-Esparza, Intracellular antigens released from Balb/c mice kidneys under chemically induced apoptosis and/or necrosis , Reumatismo: Vol. 60 No. 2 (2008)
- A.R. Giardina, A. Accardo-Palumbo, F. Ciccia, A. Ferrante, A. Principato, R. Impastato, G. Triolo, Blocking TNF in vitro with infliximab determines the inhibition of expansion and interferon gamma production of Vγ9/Vδ2 T lymphocytes from patients with active rheumatoid arthritis. A role in the susceptibility to tuberculosis? , Reumatismo: Vol. 61 No. 1 (2009)
<< < 36 37 38 39 40 41 42 43 44 > >>
You may also start an advanced similarity search for this article.